Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence
PROTOGLUT
1 other identifier
interventional
78
1 country
3
Brief Summary
Urinary incontinence (UI) is estimated to affect 25% à 45 % women all over the world. UI is associated with a poor Quality of life, with a strong level of certainty. Stress urinary incontinence (SUI) is the second more prevalent type of UI . First-line treatment for SUI is conservative, non-drug and non-surgical treatment. Among these techniques, physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) as a first-line treatment; however, only half of women with SUI are cured with PFMT. Brain imaging shows that PFMs (involved in continence mechanisms) and gluteal muscles can activate the same cortical region. This synergy is found if the gluteal muscles are voluntarily activated, but not if the PFMs are volontary activated alone . In women, hip abductor physiotherapy is a common practice which has already been the subject of a very extensive literature and has largely shown its effectiveness in the quality of lumbo-pelvic control, balance, quality of life and risk of fall prevention. This rehabilitation is based on exercises that induce solicitation of the hip abductors by synergistic reflex activation during a range of well-known exercises. Recent work has shown the effect of hip abductors on the activation of the PFMs . Until today, there is no literature evaluating the effectiveness of a hip abductors training program without associated voluntary contraction of the PFMs (PPM) on UI. The hypothesis of this work will be to demonstrate that a complementary training focused on the hip abductor, complementary to concomitant PFMT, would benefit from a more significant improvement in continence, and also in physical abilities and quality of life. Because balance seems involved in UI, we therefore propose to to observe the effects on the frontal balance of the pelvis. As the investigators have already done in previous studies, to identifying factors that predict the success of our interventions, investiagtors have planned to evaluate the observance and adherence of our patients .Complementary, the investigators planned to evaluate the effect of both intervention on pelvic floor muscles and hip abductors strength and endurance, pelvic organ prolapse symptoms and quality of life. For this objective, the investigators intend to compare two randomized parallel groups: Group A follow a 12 sessions supervised PFMT + home based PFMs exercices. Group B follow a 12 sessions supervised PFMT + home based hip abductor exercices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedStudy Start
First participant enrolled
September 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 23, 2026
September 24, 2025
September 1, 2025
2.7 years
November 3, 2022
September 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The difference in the number of leaks per week observed after the end of treatment between the two arms at the last physiotherapy session.
This number of leaks per week will be recorded using question 3 of the International Consultation on Incontinence Questionnaire (ICIQ-SF).
10 weeks
Secondary Outcomes (14)
Measurement in centimeters of the offset in the frontal plane of the postero-superior iliac spines during a one leg stance
10 weeks
Average of the measurement in Newton of the force of the hip abductors during a maximum manual resistance test repeated 3 times using a dynamometer
10 weeks
Average of measurement in seconds of the hip abductors resistance during a manual resistance test repeated 10 times
10 weeks
Measurement rated from 1 to 5 of the strength of PFMs according to the "Modified Oxford Grading Scale" testing
10 weeks
Overall score and sub-scores of urinary symptoms from the international consultation on incontinence questionnaire
10 weeks
- +9 more secondary outcomes
Study Arms (2)
physiotherapist-supervised pelvic floor muscle training
ACTIVE COMPARATORphysiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) and self training PFMT
hip abductors self training program
EXPERIMENTALphysiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) and self training hip abductors self training program
Interventions
hip abductors self training program during 7 to 10 weeks associate with a PFMT
Standard pelvic floor muscle training
Standard pelvic floor muscle training self training
Eligibility Criteria
You may qualify if:
- Women ≥ 18 ans
- patient with urinary incontinence according to the ICS criteria \[3\]
- having received a prescription for perineal rehabilitation
- affiliated to french health care insurance
- Patient having read and understood the information letter and signed the consent form
You may not qualify if:
- Bladder pathologies (cyst, tumour, interstitial cystitis)
- Neurological pathologies (multiple sclerosis, Parkinson's desease, etc.)
- Pregnant or parturient or breastfeeding woman or absence of proven contraception
- Person deprived of liberty by administrative or judicial decision or a person placed under the safeguard of justice, or guardianship or curatorship
- Physical inability to perform hip abductors exercises (unable to walk or stand independently)
- Women having scheduled continence surgery before the end of physiotherapy sessions at the time of randomization
- Women having at least one of the continence-specific anticholinergic treatments prescribed before the end of the physiotherapy sessions at the time of randomization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Rouenlead
- GIRCI NOcollaborator
Study Sites (3)
Pôle santé de la Grace Dieu
Caen, France
Chu Rouen
Rouen, France
Médipôle du Rouvray
Saint-Étienne-du-Rouvray, France
Related Publications (4)
Stewart WF, Hirsh AG, Kirchner HL, Clarke DN, Litchtenfeld MJ, Minassian VA. Urinary incontinence incidence: quantitative meta-analysis of factors that explain variation. J Urol. 2014 Apr;191(4):996-1002. doi: 10.1016/j.juro.2013.10.050. Epub 2013 Oct 16.
PMID: 24140547BACKGROUNDEbbesen MH, Hunskaar S, Rortveit G, Hannestad YS. Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT). BMC Urol. 2013 May 30;13:27. doi: 10.1186/1471-2490-13-27.
PMID: 23721491BACKGROUNDPizzol D, Demurtas J, Celotto S, Maggi S, Smith L, Angiolelli G, Trott M, Yang L, Veronese N. Urinary incontinence and quality of life: a systematic review and meta-analysis. Aging Clin Exp Res. 2021 Jan;33(1):25-35. doi: 10.1007/s40520-020-01712-y. Epub 2020 Sep 22.
PMID: 32964401BACKGROUNDHay-Smith EJC, Starzec-Proserpio M, Moller B, Aldabe D, Cacciari L, Pitangui ACR, Vesentini G, Woodley SJ, Dumoulin C, Frawley HC, Jorge CH, Morin M, Wallace SA, Weatherall M. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD009508. doi: 10.1002/14651858.CD009508.pub2.
PMID: 39704322DERIVED
Related Links
- Steenstrup B, M. Pavy Lebrun, Aigueperse N, Quemener N, Cheveau S, Confalonieri C, Totte F. Efficacité d'une rééducation sensori-motrice posturale réflexe sur l'incontinence urinaire et l'urgenturie chez la femme. Kinesith Rev. 2019;19(206):12-18
- Steenstrup B, Behague L, Quehen M. Rééducation posturale avec le jeu virtuel Wii ® en pelvi périnéologie: pourquoi pas? Kinésith Rev. 2015;15(160):45-50
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2022
First Posted
December 2, 2022
Study Start
September 28, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
September 23, 2026
Last Updated
September 24, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share